Live Investor Briefing – Prescient Therapeutics

(PTX:ASX) Prescient Therapeutics

Live Investor Briefing

Wednesday, August 12th at 7pm AEST

Please join Reach Markets Managing Director Patrick Nelson and Prescient Therapeutics CEO Steven Yatomi-Clarke for a live investor briefing.

Event Details:

Date: Wednesday 12th August
Time: 7pm AEST
Event Topics:

  • Moving the cancer conversation from “fight” to “cure” with 100% response rates as shown in a recent Johnson & Johnson trial
  • PTX’s relationship with the University of Pennsylvania, the minds behind the original CAR-T breakthrough
  • PTX’s goal of becoming the “Intel Inside” personalised cancer therapy, and more
  • How two  of PTX’s assets have been chosen as part of a COVID-19 screen program

These are live and interactive sessions, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.

Book Your Spot

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets have been engaged to help manage our investor communications.

What is a 708 investor?